Cholangiocarcinoma Clinical Trials in Seongnam-si, Gyeonggi-do
2 recruitingSeongnam-si, Gyeonggi-do, South Korea
Showing 1–2 of 2 trials
Recruiting
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
Biliary Tract CancerCholangiocarcinoma
CHA University100 enrolled1 locationNCT06648057
Recruiting
Phase 3
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
Cholangiocarcinoma
TransThera Sciences (Nanjing), Inc.200 enrolled87 locationsNCT05948475